Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy

Hospital Mutua Terrassa, Terrassa

Humboldt Universitat Charite, Campus Virchow, Neurologisch, Berlin

Neurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson Beelitz, Beelitz-Heilstätten

Hospital de Donostia, Donostia / San Sebastian

Dpt. Neurologia. Hospital Ramón y Cajal., Madrid

Hospital U. La Paz, Madrid

Hospital Puerta del Hierro, Madrid

Medizinische Hochschule Hannover, Neurologie 0E 7210, Hanover

Mayo Clinic Jacksonville, Jacksonville

University of South Florida 5, Tampa

Zentrum fur Nervenheilkunde. Klinik fur Neurologie mit Poliklinik., Marburg

Division of Movement Disorders, University of Louisville, Louisville

Hospital de Cruces, Barakaldo

University Hospital Tuebingen,Eberhard-Karls-Universitat, Universitatsklinikum Neurologie, Tübingen

Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles

The Parkinson's and Movement Disorder Institute, Fountain Valley

Departement of Neurology, Hospital La Fe, Valencia

University of Medicine and Dentistry, Robert Wood Johnson Medical School, New Brunswick

Universitatsklinikum Carl-Guslav-Carus, Technische Universitat Dresden, Klinik und Poliklinik fur Neurologie, Dresden

Fundació Ace, Barcelona

Dpto.neurologia. H. Clinic., Barcelona

The Walton Centre for Neurology and Neurosurgery NHS Trust, Liverpool

Reta Lila Weston Institute of Neurological Studies,Sara Koe PSP Research Centre, London

Clinical Ageing Research Unit, Newcastle upon Tyne